Serum mRNA as a Biomarker for Cancer Diagnosis
Author Information
Author(s): Miura Norimasa, Hasegawa Junichi, Shiota Goshi
Primary Institution: Tottori University
Hypothesis
Can circulating mRNA serve as a reliable biomarker for the early detection of various malignancies?
Conclusion
Serum hTERT mRNA is a promising biomarker for the early detection of hepatocellular carcinoma and other malignancies.
Supporting Evidence
- Circulating mRNA can reflect recent biological events in the body.
- Serum hTERT mRNA showed higher values in patients with HCC than in those with chronic liver diseases.
- The sensitivity and specificity of hTERT mRNA in HCC detection were 88.2% and 70.0%, respectively.
- Significant correlations were found between hTERT mRNA levels in serum and tumor tissue.
- ROC curve analysis indicated that hTERT mRNA is superior to conventional tumor markers.
Takeaway
Doctors can use a simple blood test to find cancer by looking for special pieces of RNA that come from tumors.
Methodology
Quantitative real-time RT-PCR was used to measure serum hTERT mRNA levels in patients with various cancers.
Limitations
The method may be influenced by conditions in organs with rich blood flow, such as the liver.
Participant Demographics
The study included 154 subjects: 64 with HCC, 20 with liver cirrhosis, 20 with chronic hepatitis, and 50 healthy individuals.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website